Company News

This press release is posted as a service by Angioplasty.Org
Medtronic Inc.
Company Press Releases
Sep 18, 2009 Medtronic Expects New Data on Drug-Eluting Stents and Transcatheter Heart Valves to Feature at TCT 2009
Aug 25, 2009 Medtronic Reports First Quarter Revenue of $3.9 Billion
Aug 14, 2009 Medtronic to Announce Financial Results for Its First Fiscal Quarter
Aug 6, 2009 Medtronic Awarded $57 Million in Patent Dispute with AGA Medical Corporation
Jul 27, 2009 Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes
Jun 15, 2009 Talent Stent Graft Shows Durable Performance in Patients with Abdominal Aortic Aneurysms
May 20, 2009 Medtronic’s CoreValve Shows Subclavian Access Success in Patients Contraindicated for Femoral Approach
May 19, 2009 Endeavor Drug-Eluting Stent Is First to Receive CE Mark for Treating Acute Coronary Syndrome
May 19, 2009 New Data From ENDEAVOR-II Challenges Conventional Wisdom on Drug-Eluting Stents
May 18, 2009 Medtronic to Participate in the Piper Jaffray Post-EuroPCR Summit
May 15, 2009 New Data on Endeavor Stent's Long-Term Safety and Efficacy to Be Featured at Interventional Cardiology Congress
May 14, 2009 Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
Apr 27, 2009 Medtronic Starts Enrollment in THRIVE, U.S. Post-Market Study of the Talent ™ Thoracic Stent Graft
Apr 3, 2009 Medtronic Launches Driver Sprint RX Coronary Stent System Worldwide

Source: Medtronic Inc.

Angioplasty.Org Home •  PatientCenter

this press release is posted as a reader service by Angioplasty.org,
 an independent educational health site
which receives support from
Medtronic, Inc., Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
All content, including text, photos and video
© Copyright Venture Digital LLC 1996-2009